PubRank
Search
About
V S Zueva
Author PubWeight™ 4.93
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Specific fragmentation of tRNA and rRNA at a 7-methylguanine residue in the presence of methylated carrier RNA.
Eur J Biochem
1985
1.03
2
[Interferon inhibition of the development of a staphylococcal infection].
Antibiot Med Biotekhnol
1985
0.82
3
[Effect of interferon type I on the in vivo persistence of Salmonella typhimurium].
Zh Mikrobiol Epidemiol Immunobiol
1986
0.81
4
A new approach to establishing the set of phages for typing methicillin-resistant Staphylococcus aureus.
J Chemother
1991
0.78
5
Mucoadjuvant properties of lipo- and glycoconjugated derivatives of oligochitosans.
Eur J Med Chem
2008
0.77
6
[Isolation and determination of activity of IgA1 protease from Neisseria meningitidis].
Bioorg Khim
2010
0.76
7
[Role of lysogenizing phages in the spread of drug-resistance plasmids in a staphylococcal population].
Zh Mikrobiol Epidemiol Immunobiol
1984
0.75
8
[Mechanism of disorders of transmission of extrachromosomal determinants of resistance in staphylococci].
Zh Mikrobiol Epidemiol Immunobiol
1971
0.75
9
[Antistaphylococcal activity in interferon preparations].
Antibiotiki
1982
0.75
10
[Effect of certain compounds on the transmission of extrachromosomal determinants of drug resistance in staphylococci].
Zh Mikrobiol Epidemiol Immunobiol
1970
0.75
11
[Enhanced activity of the protective factors in patients with suppurative surgical infection using interferon preparations].
Antibiot Med Biotekhnol
1985
0.75
12
[On the mechanism of the inhibition of microbial viability during their development in an inflammatory focus].
Zh Mikrobiol Epidemiol Immunobiol
1965
0.75
13
[Transmission of extrachromosomal drug resistance in staphylococci present in animals and the effect of neomycin on this process].
Antibiotiki
1970
0.75
14
[Transmissivity of drug resistance in Salmonella].
Antibiotiki
1975
0.75
15
[Disorders in the transmission of extrachromosomal determinants of resistance in staphylococci following preliminary treatment of the microbes with neomycin].
Biull Eksp Biol Med
1972
0.75
16
Half-of-the-sites reactivity in immobilized hybrids of glyceraldehyde-3-phosphate dehydrogenase.
FEBS Lett
1979
0.75
17
[Interferon and bacterial infections].
Antibiot Med Biotekhnol
1987
0.75
18
[Distribution of carriers of resistant Staphylococcus strains among healthy persons and its connection with the use of antibiotics].
Antibiotiki
1970
0.75
19
[Intensity of transmission of the extrachromosomal determinant of resistance in staphylococci in vitro and in vivo].
Zh Mikrobiol Epidemiol Immunobiol
1972
0.75
20
[Effect of periods in the use of antibiotics on the formation rate of drug-resistant Staphylococcal populations in patients].
Antibiotiki
1973
0.75
21
[Transmissivity of the various R factors found among E. coli cultures circulating under natural conditions].
Antibiotiki
1975
0.75
22
[Genetics of staphylococcal plasmids].
Zh Mikrobiol Epidemiol Immunobiol
1982
0.75
23
[Conjugative plasmid transfer in Staphylococcus aureus?].
Zh Mikrobiol Epidemiol Immunobiol
1994
0.75
24
Association between phage DNA injection and generation of the protonmotive force in Staphylococcus aureus.
Zentralbl Bakteriol
1989
0.75
25
[A new collection of phages for typing methicillin resistant Staphylococcus aureus].
Zh Mikrobiol Epidemiol Immunobiol
1994
0.75
26
[Methicillin-resistant Staphylococci].
Zh Mikrobiol Epidemiol Immunobiol
1988
0.75
27
[Proliferative activity of Mycobacterium tuberculosis isolated from tissues of an infected organism].
Probl Tuberk
1969
0.75
28
[Sensitivity to chemotherapeutic agents of Mycobacterium tuberculosis after brief stay in the organism of albino mice].
Antibiotiki
1968
0.75
29
[Drug resistant staphylococci in surgical departments].
Khirurgiia (Mosk)
1972
0.75
30
[Antitoxic activity of interferon preparations].
Antibiot Med Biotekhnol
1985
0.75
31
[Urgent immunocorrection in crush syndrome].
Ross Med Zh
1992
0.75
32
[Specific binding of tubazid by tuberculosis mycobacteria after contact with trypsinized homogenate of spleen].
Probl Tuberk
1968
0.75
33
[Action of inhibitors of the energy processes on the efficiency of staphylococcal phage infection].
Mol Gen Mikrobiol Virusol
1986
0.75
34
[The prevalence of staphylococci with extrachromosomal drug resistance factors in different collectives].
Zh Mikrobiol Epidemiol Immunobiol
1972
0.75
35
[Drug resistance stability in staphylococci under different conditions. The mechanism of the recovery of streptomycin sensitivity of a staphylococcal population in patients 7 months after hospital discharge].
Antibiotiki
1978
0.75
36
[Methods for detecting drug-resistant staphylococci in the human body under natural conditions].
Antibiotiki
1975
0.75
37
[Stability of drug resistance in staphylococci under various conditions and the effect on it of prolonged culture storage on artificial nutrient media].
Antibiotiki
1978
0.75
38
[Clinical and laboratory effect of leukinferon in purulent infections].
Antibiot Khimioter
1990
0.75
39
[Molecular biological characteristics of staphylococcal plasmids].
Antibiotiki
1984
0.75
40
[Effect of interferon type I on staphylococcal persistence and indices of body immunoreactivity].
Zh Mikrobiol Epidemiol Immunobiol
1984
0.75
41
[Phage-mediated conjugative transfer of plasmids in Staphylococcus aureus].
Antibiot Khimioter
1992
0.75
42
[A system of step-by-step differentiation of methicillin-resistant Staphylococcus aureus].
Antibiot Khimioter
1997
0.75
43
[Staphylococcus aureus phages].
Zh Mikrobiol Epidemiol Immunobiol
1989
0.75
44
[The proliferative activity of staphylococci isolated from different segments of the population].
Biull Eksp Biol Med
1967
0.75
45
[In vivo stability of various drug resistance plasmids in staphylococci].
Zh Mikrobiol Epidemiol Immunobiol
1978
0.75
46
[Action of different interferon preparations on pathogenic microorganisms].
Mikrobiol Zh
1983
0.75
47
[Effects of trypsin and the products of trypsinization of the liver, lung and spleen on the sensitivity of Mycobacterium tuberculosis to chemotherapeutic substances].
Probl Tuberk
1967
0.75
48
[Effect of acridine compounds on the development of drug resistance to antitubercular agents of Mycobacterium of avian type].
Antibiotiki
1969
0.75
49
[Increasing the antibacterial action of antitubercular agents through the use of acridine derivatives].
Probl Tuberk
1969
0.75
50
[Interferon preparations in the complex treatment of bacterial infections].
Antibiot Khimioter
1989
0.75
51
[Changes in the bactericidal activity of macrophages from mice with various degrees of resistance to Salmonella typhimurium infection as affected by interferon].
Zh Mikrobiol Epidemiol Immunobiol
1988
0.75
52
[Protective properties of recombinant IgA1 protease from meningococcus].
Biomed Khim
2014
0.75
53
[Specific binding of kanamycin by Mycobactrium tuberculosis after its contact with body tissues].
Antibiotiki
1968
0.75
54
[Effect of interferon on the absorption of staphylococci by the macrophages of mouse peritoneal exudate].
Mikrobiol Zh
1989
0.75
55
[Dynamics od streptomycin sensitivity in staphylococci from the nasal mucosa of patients after discharge from a surgical hospital].
Zh Mikrobiol Epidemiol Immunobiol
1979
0.75
56
[Role of prophages in the formation of antibiotic-resistant populations of Staphylococcus in the process of transformation, transduction and conjugation].
Antibiot Khimioter
1996
0.75
57
[Comparative findings on the stability of plasmid resistance to antibiotics in vitro and in vivo].
Biull Eksp Biol Med
1978
0.75
58
[Cleavage of tRNA and rRNA at 7-methylguanine in the presence of methylated carrier RNA].
Biokhimiia
1984
0.75
59
[Effect of the synthetic preparation B 58 on the activity of natural killer and cytostatic cells of the mouse spleen].
Biull Eksp Biol Med
1987
0.75
60
[Effect of proflavin on the chemotherapeutic activity of isoniazid and streptomycin in albino mice with experimental tuberculosis].
Probl Tuberk
1970
0.75
61
[Dynamics of the antibiotic sensitivity of the staphylococci in suppurative, inflammatory foci in patients during the period of the hospital stay].
Antibiotiki
1975
0.75
62
Enhancement of antituberculosis-drug action by acridines.
Lancet
1968
0.75
63
[Role of antibiotics used under various conditions of air semination with drug resistant Staphylococci in the formation of resistant microbial populations in the human organism].
Antibiotiki
1972
0.75
64
[Theoretical substantiation of methods for limiting the circulation of drug-resistant staphylococci].
Antibiotiki
1984
0.75
65
[Interferon enhances the bactericidal activity of peritoneal exudate macrophages against Salmonella typhimurium in mice].
Zh Mikrobiol Epidemiol Immunobiol
1987
0.75
66
[Transfer of drug resistance plasmids from Staphylococcus epidermidis to Staphylococcus aureus in mixed culture].
Zh Mikrobiol Epidemiol Immunobiol
1978
0.75
67
[The effect of leukinferon on the activity of phagocytosing cells in human salmonellosis].
Zh Mikrobiol Epidemiol Immunobiol
1991
0.75
68
[Sialylation of N-carbohydrate chains of glycoproteins with immobilized trans-sialidase from Trypanosoma cruzi].
Bioorg Khim
2004
0.75
69
[Method of determining the sensitivity of Staphylococcus aureus to methicillin].
Antibiotiki
1976
0.75
70
[Mechanism of the heterogeneity of a staphylococcal population with respect to methicillin resistance].
Antibiotiki
1976
0.75
71
[The mechanism of the resistance of methicillin-resistant Staphylococcus aureus to phages from the International Collection].
Zh Mikrobiol Epidemiol Immunobiol
1990
0.75
72
[Interferon activation of the production of a factor increasing the bactericidal properties of mouse macrophages].
Biull Eksp Biol Med
1988
0.75
73
[Modification of the method for elimination of extrachromosomal resistance factors in staphylococci].
Antibiotiki
1971
0.75
74
[Features of the metabolic activity of microbes developing in tissues of the macroorganism].
Zh Mikrobiol Epidemiol Immunobiol
1966
0.75
75
[Effect of penicillin on the intensity of formation of penicillin-resistant staphylococcal populations in the suppurative foci of patients].
Antibiotiki
1975
0.75
76
[Resistance of Shigella to antibiotics].
Antibiotiki
1974
0.75
77
[Epidemiological mechanism for the formation of drug-resistant bacterial populations].
Zh Mikrobiol Epidemiol Immunobiol
1975
0.75